FI951388A0 - Substituerade heterocykliska karboxylsyraamidestrar, deras framställning och deras användning som läkemedel - Google Patents
Substituerade heterocykliska karboxylsyraamidestrar, deras framställning och deras användning som läkemedelInfo
- Publication number
- FI951388A0 FI951388A0 FI951388A FI951388A FI951388A0 FI 951388 A0 FI951388 A0 FI 951388A0 FI 951388 A FI951388 A FI 951388A FI 951388 A FI951388 A FI 951388A FI 951388 A0 FI951388 A0 FI 951388A0
- Authority
- FI
- Finland
- Prior art keywords
- medicaments
- preparation
- carboxylic acid
- acid amide
- substituted heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4410453A DE4410453A1 (de) | 1994-03-25 | 1994-03-25 | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI951388A0 true FI951388A0 (sv) | 1995-03-23 |
| FI951388A FI951388A (sv) | 1995-09-26 |
Family
ID=6513880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI951388A FI951388A (sv) | 1994-03-25 | 1995-03-23 | Substituerade heterocykliska karboxylsyraamidestrar, deras framställning och deras användning som läkemedel |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0673930A1 (sv) |
| JP (1) | JPH07278111A (sv) |
| KR (1) | KR950032127A (sv) |
| AU (1) | AU1504495A (sv) |
| CA (1) | CA2145473A1 (sv) |
| CZ (1) | CZ73595A3 (sv) |
| DE (1) | DE4410453A1 (sv) |
| FI (1) | FI951388A (sv) |
| HU (1) | HUT72596A (sv) |
| NO (1) | NO951147L (sv) |
| PL (1) | PL307846A1 (sv) |
| ZA (1) | ZA952410B (sv) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0206711D0 (en) * | 2002-03-21 | 2002-05-01 | Isis Innovation | HIF Inhibitor |
| US7915443B2 (en) * | 2006-11-16 | 2011-03-29 | Allergan, Inc. | Sulfoximines as kinase inhibitors |
| US8558002B2 (en) | 2006-11-16 | 2013-10-15 | Allergan, Inc. | Sulfoximines as kinase inhibitors |
| CN112250627B (zh) | 2014-10-06 | 2024-02-02 | 弗特克斯药品有限公司 | 囊性纤维化跨膜转导调节因子调节剂 |
| ES2946970T3 (es) | 2016-03-31 | 2023-07-28 | Vertex Pharma | Regulador de conductancia transmembrana de moduladores de fibrosis quística |
| EP3519401B1 (en) | 2016-09-30 | 2021-09-29 | Vertex Pharmaceuticals Incorporated | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
| IL277491B (en) | 2016-12-09 | 2022-08-01 | Vertex Pharma | Modulatory modulation of transmembrane conductance in cystic fibrosis, pharmaceutical preparations, treatment methods, and a process for creating the modulator |
| EP3634402A1 (en) | 2017-06-08 | 2020-04-15 | Vertex Pharmaceuticals Incorporated | Methods of treatment for cystic fibrosis |
| AU2018304168B2 (en) | 2017-07-17 | 2023-05-04 | Vertex Pharmaceuticals Incorporated | Methods of treatment for cystic fibrosis |
| CN111051280B (zh) | 2017-08-02 | 2023-12-22 | 弗特克斯药品有限公司 | 制备吡咯烷化合物的方法 |
| US10654829B2 (en) | 2017-10-19 | 2020-05-19 | Vertex Pharmaceuticals Incorporated | Crystalline forms and compositions of CFTR modulators |
| MX2020005753A (es) | 2017-12-08 | 2020-08-20 | Vertex Pharma | Procesos para producir moduladores de regulador de conductancia transmembranal de fibrosis quistica. |
| TWI810243B (zh) | 2018-02-05 | 2023-08-01 | 美商維泰克斯製藥公司 | 用於治療囊腫纖化症之醫藥組合物 |
| EP3774825A1 (en) | 2018-04-13 | 2021-02-17 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-03-25 DE DE4410453A patent/DE4410453A1/de not_active Withdrawn
-
1995
- 1995-03-09 EP EP95103405A patent/EP0673930A1/de not_active Withdrawn
- 1995-03-23 AU AU15044/95A patent/AU1504495A/en not_active Abandoned
- 1995-03-23 CZ CZ95735A patent/CZ73595A3/cs unknown
- 1995-03-23 FI FI951388A patent/FI951388A/sv unknown
- 1995-03-24 PL PL95307846A patent/PL307846A1/xx unknown
- 1995-03-24 HU HU9500863A patent/HUT72596A/hu unknown
- 1995-03-24 JP JP7065927A patent/JPH07278111A/ja active Pending
- 1995-03-24 NO NO951147A patent/NO951147L/no unknown
- 1995-03-24 ZA ZA952410A patent/ZA952410B/xx unknown
- 1995-03-24 CA CA002145473A patent/CA2145473A1/en not_active Abandoned
- 1995-03-25 KR KR1019950006806A patent/KR950032127A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL307846A1 (en) | 1995-10-02 |
| NO951147L (no) | 1995-09-26 |
| NO951147D0 (no) | 1995-03-24 |
| ZA952410B (en) | 1995-12-01 |
| KR950032127A (ko) | 1995-12-20 |
| AU1504495A (en) | 1995-10-05 |
| HUT72596A (en) | 1996-05-28 |
| EP0673930A1 (de) | 1995-09-27 |
| DE4410453A1 (de) | 1995-09-28 |
| FI951388A (sv) | 1995-09-26 |
| CZ73595A3 (en) | 1995-11-15 |
| JPH07278111A (ja) | 1995-10-24 |
| CA2145473A1 (en) | 1995-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200100258A (et) | Antraniilhappe amiidid ja nende kasutamine ravimitena | |
| HUP9903405A3 (en) | Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids with metalloproteinase inhibitor activity, preparation and use thereof | |
| DE59706602D1 (de) | 3-Hydroxy-Pyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel | |
| IL110821A0 (en) | Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids and pharmaceutical compositions comprising them | |
| NO924978L (no) | Chinolon- og naftyridon-karboksylsyrederivater | |
| FI940874A0 (sv) | Förfarande för framställning av mjöksyra och mjölksyraestrar | |
| FI951388A (sv) | Substituerade heterocykliska karboxylsyraamidestrar, deras framställning och deras användning som läkemedel | |
| EE9500059A (et) | Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena | |
| EE03767B1 (et) | Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat | |
| FI940216A0 (sv) | Kinolon- och naftyridonkarboxylsyraderivat | |
| FI954255A0 (sv) | 2,9-diamino- och 2-amino-8-karbamoyl-4-hydroxi-alkansyraamidderivat | |
| EE9900034A (et) | Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine | |
| DK0673647T3 (da) | Dermatologisk sammensætning indeholdende mælkesyresalt | |
| FI951726A0 (sv) | Boronsyrapeptidderivat, deras framställning och användning som syntes-mellanprodukter | |
| FI960634A (sv) | Nya kinolonkarboxylsyraderivat | |
| HUP0000084A3 (en) | 3-alkoxyisoxazol-4-yl-substituted-2-amino carboxylic acid derivatives, their use and pharmaceutical compositions containing them | |
| FI951385A0 (sv) | Substituerade heterocykliska karboxylsyraamider, deras framställning och deras användning som läkemedel | |
| EE9500055A (et) | 1,4-dihüdropüridiin-3,5-dikarboksüülhappeestrite kasutamine ravimitena, ravimid ja nende valmistamismeetod | |
| FI951725A (sv) | Aminoboronsyraderivat, framställning av dessa och användning av dessa som syntesmellanprodukter | |
| HUP0100957A3 (en) | 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same, their use and pharmaceutical compositions containing them | |
| NO960777D0 (no) | Anvendelse av N-alkylerte 1,4-dihydropyridin dikarboksylsyreestere som medikamenter | |
| FI941082A0 (sv) | Kinolonkarboxylsyraderivat, deras framställning och användning | |
| NO923114D0 (no) | Heterocykliske karboksylsyreestere, fremgangsmaater for fremstilling av dem og anvendelse av dem for fremstilling avgastro-intestinale medisiner | |
| FI971012A (sv) | 1,4-dihydro-4-oxo-3-kinolinkarboxylsyraderivat och deras användning | |
| ZA948579B (en) | Substituted heterocyclic carboxamide esters,their preparation and their use as pharmaceuticals |